FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Accepts Medacs Treosulfan NDA Resubmission

Medexus Pharmaceuticals says FDA has accepted for review its Medac licensors resubmitted NDA for treosulfan, indicated for combination use with fludar...

latest-news-card-1
Human Drugs

FDA Reviewers Air Alzheimers Drug Issues

FDA medical reviewer raise some issues about Lillys investigational Alzheimers drug donanemab for advisory committee members to consider.

latest-news-card-1
Medical Devices

GAO Cites OTC Hearing Aid Issues

The Government Accountability Office says stakeholder groups have identified issues with OTC hearing aids that need to be monitored.

latest-news-card-1
Human Drugs

Reps Seek Info for Next Generation Cures

Reps. DeGette and Buchson ask for input on steps Congress can take to help develop the next generation of healthcare treatments.

latest-news-card-1
Human Drugs

Workshop on AI Use in Drug/Biologic Development

FDA and the Clinical Trials Transformation Initiative announce an 8/6 hybrid public workshop on artificial intelligence in drug and biological product...

latest-news-card-1
Medical Devices

Pediatric Orthopedic Device Innovation Lags: Research

University of MissouriKansas City researchers say pediatric orthopedic device innovation lags substantially behind adult device innovation.

latest-news-card-1
Medical Devices

Diasorin Liaison Plex Assay Cleared

FDA clears a Diasorin 510(k) for its Liaison Plex Yeast Blood Culture Assay for microbiological diagnosis of bloodstream infections.

latest-news-card-1
Human Drugs

FDA Places Hold on Biomea Diabetes Trials

FDA places a clinical hold on Biomea Fusions Phase 1-2 clinical trials of its investigational covalent menin inhibitor BMF-219 in Type 2 and Type 1 di...

latest-news-card-1
Biologics

BIMO Electronic Submission Format Guidance

FDA publishes a draft guidance outlining the standardized format for electronic submission of BLA, NDA, and selected supplements for planning CBER Bio...

latest-news-card-1
Federal Register

Info Collection on Rx Drug Marketing

Federal Register notice: FDA sends to OMB an information collection extension entitled Prescription Drug Marketing.